Search Results - "MacLeod, R A"

Refine Results
  1. 1

    JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders by QUENTMEIER, H, MACLEOD, R. A. F, ZABORSKI, M, DREXLER, H. G

    Published in Leukemia (01-03-2006)
    “…A mutation in the JH2 pseudokinase domain of the Janus kinase 2 gene (JAK2 V617F) has been described in chronic myeloproliferative disorders (MPD). We screened…”
    Get full text
    Journal Article
  2. 2

    Personalised 3D Printed high tibial osteotomy achieves a high level of accuracy: 'IDEAL' preclinical stage evaluation of a novel patient specific system by MacLeod, A R, Mandalia, V I, Mathews, J A, Toms, A D, Gill, H S

    Published in Medical engineering & physics (01-10-2022)
    “…High tibial osteotomy (HTO) is an effective surgical treatment for isolated medial compartment knee osteoarthritis; however, widespread adoption is limited due…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma by Meads, M B, Fang, B, Mathews, L, Gemmer, J, Nong, L, Rosado-Lopez, I, Nguyen, T, Ring, J E, Matsui, W, MacLeod, A R, Pachter, J A, Hazlehurst, L A, Koomen, J M, Shain, K H

    Published in Oncogene (01-05-2016)
    “…Multiple myeloma (MM) remains an incurable malignancy due, in part, to the influence of the bone marrow microenvironment on survival and drug response…”
    Get full text
    Journal Article
  5. 5

    A Biomechanical Comparison of Plate Configuration in Distal Humerus Fractures by Arnander, Magnus W T, Reeves, Alexander, MacLeod, Iain A R, Pinto, Thomas M, Khaleel, Arshad

    Published in Journal of orthopaedic trauma (01-05-2008)
    “…OBJECTIVES:Our aim was to test the hypothesis that two plates placed parallel to each other are stronger and stiffer than plates placed perpendicular to each…”
    Get full text
    Journal Article
  6. 6

    High level EGFR amplification in a newly established glioblastoma cell line 170-MG-BA by MacLeod, R A F, Schneider, B, Sivakova, I, Nagel, S, Dirks, W G, Mraz, P, Kubikova, E, Perzelova, A

    Published in Neoplasma (01-01-2019)
    “…Glioblastoma multiforme is a highly invasive and incurable primary brain tumor. The most frequent genetic alteration therein is amplification of the epidermal…”
    Get more information
    Journal Article
  7. 7

    MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines by Nagel, S, Meyer, C, Quentmeier, H, Kaufmann, M, Drexler, H G, MacLeod, R A F

    Published in Leukemia (01-03-2008)
    “…In T-cell acute lymphoblastic leukemia (T-ALL) the cardiac homeobox gene NKX2-5 (at 5q35) is variously deregulated by regulatory elements coordinating with…”
    Get full text
    Journal Article
  8. 8

    U-2932: two clones in one cell line, a tool for the study of clonal evolution by Quentmeier, H, Amini, R M, Berglund, M, Dirks, W G, Ehrentraut, S, Geffers, R, MacLeod, R A F, Nagel, S, Romani, J, Scherr, M, Zaborski, M, Drexler, H G

    Published in Leukemia (01-05-2013)
    “…Genetic heterogeneity is common in tumors, explicable by the development of subclones with distinct genetic and epigenetic alterations. We describe an in vitro…”
    Get full text
    Journal Article
  9. 9

    Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma by Nagel, S, Leich, E, Quentmeier, H, Meyer, C, Kaufmann, M, Drexler, H G, Zettl, A, Rosenwald, A, MacLeod, R A F

    Published in Leukemia (01-02-2008)
    “…Recurrent chromosomal aberrations in hematopoietic tumors target genes involved in pathogenesis. Their identification and functional characterization are…”
    Get full text
    Journal Article
  10. 10

    SOCS2: inhibitor of JAK2V617F-mediated signal transduction by Quentmeier, H, Geffers, R, Jost, E, MacLeod, R A F, Nagel, S, Röhrs, S, Romani, J, Scherr, M, Zaborski, M, Drexler, H G

    Published in Leukemia (01-12-2008)
    “…Janus kinase 2 ( JAK2 )V617F-activating mutations ( JAK2 mu) occur in myeloproliferative disorders (MPDs) and myelodysplastic syndromes (MDSs). Cell lines…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly by Stewart, D. J., Donehower, R. C., Eisenhauer, E. A., Wainman, N., Shah, A. K., Bonfils, C., MacLeod, A. R., Besterman, J. M., Reid, G. K.

    Published in Annals of oncology (01-05-2003)
    “…Background: Hypermethylation and inactivation of tumor suppressor genes by the enzyme DNA methyltransferase may lead to neoplastic transformation. MG98, a…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes by SANDBERG, Y, VERHAAF, B, VAN GASTEL-MOL, E. J, WOLVERS-TETTERO, I. L. M, DE VOS, J, MACLEOD, R. A. F, NOORDZIJ, J. G, DIK, W. A, VAN DONGEN, J. J. M, LANGERAK, A. W

    Published in Leukemia (01-02-2007)
    “…The BIOMED-2 multiplex polymerase chain reaction (PCR) tubes for analysis of immunoglobulin and T-cell receptor (TCR) gene rearrangements have recently been…”
    Get full text
    Journal Article
  16. 16

    Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations by DREXLER, H. G, QUENTMEIER, H, MACLEOD, R. A. F

    Published in Leukemia (01-02-2004)
    “…Human tumor cell lines are powerful tools for investigating basic and applied aspects of cell biology. Leukemia-lymphoma cell lines have been instrumental in…”
    Get full text
    Journal Article
  17. 17

    Regulation of DNA Methylation by the Ras Signaling Pathway by MacLeod, A. Robert, Rouleau, Julie, Szyf, Moshe

    Published in The Journal of biological chemistry (12-05-1995)
    “…We demonstrate that DNA methylation in an adrenocortical tumor cell line, Y1, is controlled by the Ras signaling pathway. Forced expression of a cDNA encoding…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin by QUENTMEIER, H, MARTELLI, M. P, MARTELLI, M. F, MECUCCI, C, DREXLER, H. G, FALINI, B, DIRKS, W. G, BOLLI, N, LISO, A, MACLEOD, R. A. F, NICOLETTI, I, MANNUCCI, R, PUCCIARINI, A, BIGERNA, B

    Published in Leukemia (01-10-2005)
    “…We recently identified a new acute myeloid leukemia (AML) subtype characterized by mutations at exon-12 of the nucleophosmin (NPM) gene and aberrant…”
    Get full text
    Journal Article
  20. 20

    False leukemia-lymphoma cell lines: an update on over 500 cell lines by DREXLER, H. G, DIRKS, W. G, MATSUO, Y, MACLEOD, R. A. F

    Published in Leukemia (01-02-2003)
    “…Human leukemia-lymphoma (LL) cell lines represent an extremely important resource for research in a variety of fields and disciplines. As the cell lines are…”
    Get full text
    Journal Article